Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2534 studies found for:    PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
Show Display Options
Rank Status Study
1 Enrolling by invitation China Chronic Obstructive Pulmonary Disease Registration Research
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
2 Completed
Has Results
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Fluticasone propionate/salmeterol combination product;   Drug: Salmeterol;   Drug: Placebo
3 Completed Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
4 Completed
Has Results
A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Placebo;   Biological: Benralizumab 100 mg
5 Completed
Has Results
Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: No intervention
6 Completed A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: CNTO 6785;   Drug: Placebo
7 Recruiting Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo
8 Terminated
Has Results
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
9 Completed
Has Results
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444
10 Completed Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Subjects with COPD;   Other: Subjects without COPD
11 Enrolling by invitation European Quality of Care Pathways Study on Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Other: COPD evidence based care pathway
12 Unknown  Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Traditional Chinese Medicine;   Drug: placebo chinese medicine
13 Completed Abdominal Functional Electrical Stimulation to Reduce Hyperinflation in Chronic Obstructive Pulmonary Disease Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: Abdominal Stimulation - low / early;   Device: Abdominal stimulation - low/late;   Device: Abdominal Stimulation - low/full;   Device: Abdominal stimulation - med/early;   Device: Abdominal stimulation - med/late;   Device: Abdominal Stimulation - med/full;   Device: Abdominal Stimulation - high/early;   Device: Abdominal Stimulation - high/late;   Device: Abdominal Stimulation - high/full
14 Active, not recruiting A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Solithromycin;   Drug: Placebo
15 Completed ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Salmeterol;   Drug: Fluticasone Propionate/Salmeterol Combination Product
16 Unknown  Does Pulmonary Daoyin of China Give Additional Benefit Over Usual Therapy in Management of Stable Chronic Obstructive Pulmonary Disease?
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Pulmonary daoyin therapy of China;   Other: usual care
17 Completed Inert Dusts and Pathology of Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
18 Completed
Has Results
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
19 Completed
Has Results
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder;   Drug: FF Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo
20 Completed
Has Results
Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder;   Drug: GW642444 Inhalation Powder;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.